Joint Cluster Pharma Holding ApS
CVR 45222381 · Private limited company (ApS) · Active · Very high risk
Joint Cluster Pharma Holding ApS is a Private limited company (ApS), founded on , based in Rønde. The company is registered in the industry ikke-finansielle holdingselskaber. Our model estimates a bankruptcy risk of 7.8% over the next 12 months, which is 5.6 times the average for Danish companies. 1 annual report has been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 34k and a net result of DKK -5,763. CEO: Niels Karl Pørksen.
Bankruptcy risk for Joint Cluster Pharma Holding ApS
5.6 × the average (1.41%) · higher risk than 96% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 45222381
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (1 years)
- Address
- Søren Møllersvej 14
8410 Rønde - Municipality
- Syddjurs
- Industry
- Ikke-finansielle holdingselskaber (642120)
Bankruptcies in the industry: Ikke-finansielle holdingselskaber - Share capital
- DKK 40k
- Auditor
- Beierholm
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 1 of 1 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 85.6% |
| Current ratio | 694% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 2 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 |
|---|---|
| Gross profit | DKK -5,759 |
| Net profit | DKK -5,763 |
| Equity | DKK 34k |
| Total assets | DKK 40k |
| Short-term debt | DKK 5,763 |
| Avg. employees | 0 |
Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · Beierholm.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 15 Nov 2024 – 31 Dec 2025 | 188 | Late |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Niels Karl Pørksen | Current | |
| Owner (100%) | Niels Karl Pørksen | Current | |
| Founder | Niels Karl Pørksen | Current |
The CEOs' other companies
Niels Karl Pørksen – 2 other companies
- LeanBio ApS Active
- LeanBio Holding ApS Active
Address history (0 moves)
| Søren Møllersvej 14, 8410 Rønde |
Other companies at the same address
- LeanBio ApS Active
- LeanBio Holding ApS Active
Similar companies in Syddjurs
- HUITFELDT HOLDING A/S Rønde
- F & L EBBESTRUP HOLDING A/S Ebeltoft
- KNEBEL HOLDING ApS Ryomgård
- ALTO HOLDING ApS Mørke
- BERIT HOLDING ApS Rønde
- RBF Invest ApS Hornslet
- Murermester Rasmus Christensen Holding ApS Rønde
- Tiny Horse Holding ApS Ebeltoft
- Kasper Bargsteen Holding ApS Ebeltoft
- Jakob Lovas Holding ApS Ebeltoft
- Shanti Holding ApS Hornslet
- Morten Brøgger ApS Ebeltoft
Questions and answers about Joint Cluster Pharma Holding ApS
Has Joint Cluster Pharma Holding ApS gone bankrupt?
No, Joint Cluster Pharma Holding ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Joint Cluster Pharma Holding ApS?
Our model estimates a bankruptcy risk of 7.8% over the next 12 months (very high risk), which is 5.6 times the average for Danish companies.
Who is the CEO of Joint Cluster Pharma Holding ApS?
Niels Karl Pørksen is the CEO of Joint Cluster Pharma Holding ApS.
Who is the auditor of Joint Cluster Pharma Holding ApS?
Joint Cluster Pharma Holding ApS most recently used Beierholm.
When was Joint Cluster Pharma Holding ApS founded?
Joint Cluster Pharma Holding ApS was founded on 15 November 2024.
What is the equity of Joint Cluster Pharma Holding ApS?
Equity was DKK 34k according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.